David S. Ege - Net Worth and Insider Trading
David S. Ege Net Worth
The estimated net worth of David S. Ege is at least $85,673 dollars as of 2024-05-05. David S. Ege is the See Remarks of Seres Therapeutics Inc and owns about 73,856 shares of Seres Therapeutics Inc (MCRB) stock worth over $85,673. Details can be seen in David S. Ege's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David S. Ege has not made any transactions after 2024-02-16 and currently still holds the listed stock(s).
Transaction Summary of David S. Ege
David S. Ege Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David S. Ege owns 1 companies in total, including Seres Therapeutics Inc (MCRB) .
Click here to see the complete history of David S. Ege’s form 4 insider trades.
Insider Ownership Summary of David S. Ege
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2024-02-16 | See Remarks |
David S. Ege Latest Holdings Summary
David S. Ege currently owns a total of 1 stock. David S. Ege owns 73,856 shares of Seres Therapeutics Inc (MCRB) as of February 16, 2024, with a value of $85,673.
Latest Holdings of David S. Ege
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MCRB | Seres Therapeutics Inc | 2024-02-16 | 73,856 | 1.16 | 85,673 |
Holding Weightings of David S. Ege
David S. Ege Form 4 Trading Tracker
According to the SEC Form 4 filings, David S. Ege has made a total of 4 transactions in Seres Therapeutics Inc (MCRB) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Seres Therapeutics Inc is the sale of 5,010 shares on February 16, 2024, which brought David S. Ege around $5,411.
Insider Trading History of David S. Ege
- 1
David S. Ege Trading Performance
David S. Ege Ownership Network
David S. Ege Owned Company Details
What does Seres Therapeutics Inc do?
Who are the key executives at Seres Therapeutics Inc?
David S. Ege is the See Remarks of Seres Therapeutics Inc. Other key executives at Seres Therapeutics Inc include Chief Scientific Officer Matthew R. Henn , CFO and EVP Eric D. Shaff , and Chief Financial Officer David Arkowitz .
Seres Therapeutics Inc (MCRB) Insider Trades Summary
Over the past 18 months, David S. Ege made 3 insider transaction in Seres Therapeutics Inc (MCRB) with a net sale of 16,114. Other recent insider transactions involving Seres Therapeutics Inc (MCRB) include a net sale of 20,101 shares made by Eric D. Shaff , a net sale of 8,632 shares made by Moltke Lisa Von , and a net sale of 8,095 shares made by Thomas Desrosier .
In summary, during the past 3 months, insiders sold 36,381 shares of Seres Therapeutics Inc (MCRB) in total and bought 0 shares, with a net sale of 36,381 shares. During the past 18 months, 78,188 shares of Seres Therapeutics Inc (MCRB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 78,188 shares.
Seres Therapeutics Inc (MCRB)'s detailed insider trading history can be found in Insider Trading Tracker table.
Seres Therapeutics Inc Insider Transactions
David S. Ege Mailing Address
Above is the net worth, insider trading, and ownership report for David S. Ege. You might contact David S. Ege via mailing address: C/o Seres Therapeutics, Inc., 200 Sidney Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
